Glucagon‐like peptide‐1 receptor agonist treatment of high carbohydrate intake‐induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca 2+ abnormalities and mitochondrial dysfunction-Reference-Cited by-同舟云学术

Glucagon‐like peptide‐1 receptor agonist treatment of high carbohydrate intake‐induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca 2+ abnormalities and mitochondrial dysfunction

Published:2021-10-27 Issue:1 Volume:49 Page:46-59
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

Durak Aysegul¹,Akkus Erman²,Canpolat Asena Gokcay³,Tuncay Erkan¹,Corapcioglu Demet³,Turan Belma¹⁴

Affiliation:

1. Faculty of Medicine Department of Biophysics Ankara University Ankara Turkey

2. Faculty of Medicine Department of Internal Medicine Ankara University Ankara Turkey

3. Faculty of Medicine Department of Endocrinology and Metabolism Ankara University Ankara Turkey

4. Faculty of Medicine Department of Biophysics Lokman Hekim University Ankara Turkey

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1440-1681.13590

Reference78 articles.

1. Glucagon-like peptide 1 (GLP-1)

2. Exendin-4 inhibits structural remodeling and improves Ca 2+ homeostasis in rats with heart failure via the GLP-1 receptor through the eNOS/cGMP/PKG pathway

3. Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors

4. Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease

5. Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empowering mitochondrial metabolism: Exploring L-lactate supplementation as a promising therapeutic approach for metabolic syndrome;Metabolism;2024-03

2. Targeting mitochondrial quality control for diabetic cardiomyopathy: Therapeutic potential of hypoglycemic drugs;Biomedicine & Pharmacotherapy;2023-12

3. GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation;Journal of Pharmaceutical Analysis;2023-12

4. Electrical interaction between cardiomyocytes and non-myocytes in the metabolic heart contributes to the induction of short QT interval;2023-08-30

5. Liraglutide provides cardioprotection through the recovery of mitochondrial dysfunction and oxidative stress in aging hearts;Journal of Physiology and Biochemistry;2022-12-14